RPL21: A Potential Drug Target Or Biomarker (G6144)

Target Name: RPL21

NCBI ID: G6144

RPL21

RPL21: A Potential Drug Target Or Biomarker

RPL21 (RNA-protein complex subunit 21) is a protein that is expressed in various tissues and cells of the human body. It is a key component of the RNA-protein complex, which is a complex of RNA and protein that plays a crucial role in various cellular processes. One of the RPL21 subunits, OTTHUMP00000018163, has been identified as a potential drug target or biomarker, which may have implications for the treatment of various diseases.

History of RPL21

RPL21 is a member of the RPL21 family, which is characterized by the presence of a specific domain called the N-terminal alpha-helices. This domain is known to be involved in the formation of the RNA-protein complex. RPL21 is a 21-kDa protein that is expressed in various tissues of the human body, including the brain, heart, and liver. It is highly conserved across various species, which suggests that it may have a conserved function.

Function of RPL21

RPL21 is a key component of the RNA-protein complex, which is a complex of RNA and protein that plays a crucial role in various cellular processes. The RNA-protein complex is composed of various subunits, including RPL21, which is responsible for the stability of the complex. RPL21 helps to maintain the stability of the RNA-protein complex by interacting with various protein and RNA subunits.

One of the functions of RPL21 is to regulate the stability of the RNA-protein complex. RPL21 has been shown to interact with various protein and RNA subunits, including the protein PSF2 and RNA-protein complex subunit 20 (RPC20). These interactions help to maintain the stability of the RNA-protein complex, which is essential for the proper functioning of various cellular processes.

Another function of RPL21 is to regulate the translation of RNA into protein. RPL21 has been shown to interact with various RNA subunits, including the protein exportin (EXO)1. These interactions help to regulate the translation of RNA into protein, which is essential for the production of various proteins that are involved in cellular processes.

Potential Drug Target or Biomarker

The RPL21 subunit OTTHUMP00000018163 has been shown to have various unique properties that make it a potential drug target or biomarker. One of the properties that makes it a potential drug target is its high expression level in various tissues of the human body. This suggests that targeting RPL21 may be effective in treating various diseases.

Another property that makes RPL21 a potential drug target is its involvement in various cellular processes. RPL21 is involved in the regulation of the stability of the RNA-protein complex, which is essential for the proper functioning of various cellular processes. This suggests that targeting RPL21 may be effective in treating diseases that are caused by the disruption of these cellular processes.

Furthermore, RPL21 has also been shown to be involved in the regulation of the translation of RNA into protein. This suggests that targeting RPL21 may also be effective in treating diseases that are caused by the disruption of this critical process.

Conclusion

In conclusion, RPL21 is a protein that is expressed in various tissues and cells of the human body. It is a key component of the RNA-protein complex and is involved in various cellular processes. The RPL21 subunit OTTHUMP00000018163 has been identified as a potential drug target or biomarker due to its high expression level, involvement in the regulation of cellular processes, and involvement in the regulation of the translation of RNA into protein. Further research is needed to determine the full implications of these properties.

Protein Name: Ribosomal Protein L21

Functions: Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25957688, PubMed:25901680). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:25957688, PubMed:25901680)

The "RPL21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets